Fig. 1.
Investigator-assessed PFS in a the Japan subgroup, and b the global CAPItello-291 population. The hazard ratio was estimated in the Japan subgroup using the Cox proportional hazards model stratified by previous CDK4/6 inhibitor use, and in the global CAPItello-291 population using the Cox proportional hazards model stratified according to the presence or absence of liver metastases, previous CDK4/6 inhibitor use, and geographic region. Tick marks indicate censored data. b From New England Journal of Medicine. Turner et al. [16]. Copyright © (2023) Massachusetts Medical Society. Reprinted with permission. CI confidence interval, PFS progression-free survival
